IL-37b Gene Transfer Enhances the Therapeutic Efficacy of Mesenchumal Stromal Cells in DSS- Induced Colitis Mice

Wei-qiang Wang,Kui Dong,Lu Zhou,Guo-hui Jiao,Cong-zhong Zhu,Wen-wen Li,Gang Yu,Wan-tong Wu,Song Chen,Zhi-na Sun,Yu-ming Wang,Wen-tian Liu,Jie Zhang,Bang-mao Wang,Xiao-ming Feng

DOI: https://doi.org/10.1038/aps.2015.51

IF: 7.169

2015-01-01

Acta Pharmacologica Sinica

Abstract:Aim: To investigate whether the transfer of the IL-37b gene, a newly identified inhibitor of both innate and adaptive immunity, could improve the therapeutic efficacy of mesenchumal stromal cells (MSCs) in inflammatory bowel disease (IBD). Methods: The expression of IL-37 in biopsied specimens of the patients with active ulcerative colitis (UC) was detected using RT-PCR and immunohistochemistry. Mice were treated with 3% dextran sulfate sodium (DSS) for 8 days to induce colitis. Before DSS treatment, the mice were injected with MSCs, MSC-eGFP or MSC-IL37b. Their body weight was measured each day, and the colons and spleens were harvested on d 10 for pathological and biochemical analyses. Results: In biopsied specimens of the patients with active UC, the expression of IL-37 was dramatically elevated in inflamed mucosa, mainly in epithelial cells and infiltrating immune cells. Compared to MSC-eGFP or MSCs, MSC-IL37b administration significantly attenuated the body weight and colon length reduction, and decreased the histological score in DSS-induced colitis mice. Furthermore, MSC-IL37b administration increased the percentage of myeloid-derived suppressor cells (MDSCs) among total splenic mononuclear cells as well as the percentage of regulatory T cells (Tregs) among splenic CD4 T cells in the mice. Moreover, MSC-IL37b administration increased the IL-2 cells and decreased the IFN-γ cells among splenic CD4 T cells. Conclusion: IL-37 is involved in the pathophysiology of UC. IL-37b gene transfer enhances the therapeutic efficacy of MSCs in DSSinduced colitis mice by inducing Tregs and MDSCs and regulating cytokine production.